製品の概要

  • 製品名Charybdotoxin
  • 製品の詳細
    K+ channel blocker
  • 生理活性の詳細Blocks KCa1.1 (large conductance Ca2+ activated K+, Slo) channels in nanomolar concentrations as well as Kv1.2 (Kd = 14 nM) and Kv1.3 (Kd = 2.6 nM) channels.
  • 精製度> 98%

製品の特性

    Charybdotoxin (ab120269) 使用論文

    This product has been referenced in:
    • Grissmer S  et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227-34 (1994). Read more (PubMed: 7517498) »
    • Gimenez-Gallego G  et al. Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels. Proc Natl Acad Sci U S A 85:3329-33 (1988). Read more (PubMed: 2453055) »
    • Miller C  et al. Charybdotoxin, a protein inhibitor of single Ca2+-activated K+ channels from mammalian skeletal muscle. Nature 313:316-8 (0). Read more (PubMed: 2578618) »

    See all 3 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120269.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"